Intravenous iron therapy in non-dialysis CKD patients

被引：5
|
作者：
Macdougall, Iain C. [1 ]
机构：
[1] Kings Coll Hosp London, Dept Renal Med, Renal Unit, London, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷 / 04期
关键词：
iron deficiency; ferric carboxymaltose; intravenous iron; chronic kidney disease; randomised controlled trial; CHRONIC KIDNEY-DISEASE; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; CARE;
D O I：
10.1093/ndt/gft419
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：717 / 720
页数：4
相关论文
共 50 条
  • [41] PRIORITIES OF NUTRITIONAL ISSUES IN NON-DIALYSIS CKD ACCORDING TO STAKEHOLDERS
    Bellizzi, Vincenzo
    Carrero, Juan Jesus
    Calella, Patrizia
    Chauveau, Philippe
    Johansson, Lina
    Molina, Pablo
    Sezer, Siren
    Teta, Daniel
    Fouque, Denis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [42] THE DIFFERENTIAL EFFECT OF THIRD GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON PATIENT RELATED OUTCOME MEASURES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I383 - I384
  • [43] ADVANCE DIRECTIVES IN OLDER ADULTS WITH ADVANCED NON-DIALYSIS CKD
    Ren, Lucy
    Ladin, Keren
    Gordon, Elisa
    Rifkin, Dena
    Rossi, Ana
    Weiner, Daniel
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 651 - 651
  • [44] Tuberculosis among Kidney Transplant Patients Compared to Dialysis and Non-Dialysis CKD Patients over a Decade Period.
    Metry, A.
    Al Salmi, I.
    Al Ismaili, F.
    Hola, A.
    Shaheen, F.
    Al Salmi, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 535 - 536
  • [45] Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients
    Minutolo, Roberto
    Conte, Giuseppe
    Cianciaruso, Bruno
    Bellizzi, Vincenzo
    Camocardi, Andrea
    De Paola, Luigi
    De Nicola, Luca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2880 - 2886
  • [46] Prevalence and baseline characteristics of dialysis and non-dialysis dependent CKD patients with and without anemia: A US cohort from DISCOVER-CKD
    Wittbrodt, Eric
    Carrero, Juan Jesus
    James, Glen
    Fishbane, Steven
    Kumar, Supriya
    Pecoits-Filho, Roberto
    Sanchez, Juan Jose Garcia
    Pollock, Carol
    Sloand, James
    Hedman, Katarina
    Wheeler, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 98 - 99
  • [47] DOES DIETARY POTASSIUM INTAKE ASSOCIATE WITH HYPERKALEMIA IN NON-DIALYSIS DEPENDENT CKD PATIENTS?
    Ramos, Christiane
    Ribeiro, Bruna
    Fernandes, Andreia
    Cuppari, Lilian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [48] IS THERE RELATIONSHIP BETWEEN BODY COMPOSITION AND BONE MINERAL DENSITY IN NON-DIALYSIS CKD PATIENTS?
    Mafra, Denise
    da Silva Moura, Daiane Cristina
    dos Anjos, Juliana Saraiva
    Veiga, Paula Black
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [49] UTILITY AND CONSTRUCT VALIDITY OF THE SARC-F INSTRUMENT IN PATIENTS WITH NON-DIALYSIS CKD
    Vadaszy, Noemi
    Smith, Alice
    Wilkinson, Thomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I437 - I438
  • [50] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON HEMATINIC AND RENAL FUNCTION VARIABLES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I379 - I380
12345